Changes of the soluble fibrin monomer complex level during the perioperative period of hip replacement surgery

Journal of Orthopaedic Science

Volumn 13, Issue 5, 2008, Pages 419-424

  Misaki, Tomonori ^a   Kitajima, Isao ^b,c   Kabata, Tamon ^a   Tani, Mineko ^c   Kabata, Chiharu ^a   Tsubokawa, Tsunehisa ^a   Asakura, Hidesaku ^a   Tomita, Katsuro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c TOYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; DANAPAROID; FIBRIN; FIBRIN MONOMER; FRUCTOSE BISPHOSPHATE; HEPARIN; LUPUS ANTICOAGULANT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPRESSION GARMENT; COMPRESSION THERAPY; DOPPLER FLOWMETRY; ELECTIVE SURGERY; FEMALE; HUMAN; INCIDENCE; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LUNG SCINTISCANNING; MALE; PERIOPERATIVE PERIOD; PHLEBOGRAPHY; POSTOPERATIVE PERIOD; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

EID: 53649106356     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-008-1266-y     Document Type: Article

References (25)

1. D.A. Haake S.A. Berkman 1989 Venous thromboembolic disease after hip surgery: risk factors, prophylaxis, and diagnosis Clin Orthop 242 212 231
2. K.B. Freedman K.R. Brookenthal R.H. Fitzgerald Jr S. Williams J.H. Lonner 2000 A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty J Bone Joint Surg Am 82 929 938
3. W.H. Geerts G.F. Pineo J.A. Heit D. Bergqvist M.R. Lassen C.W. Colwell 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 338S 400S
4. R. Bos G.H. Laterveer-Vreeswijk D. Lockwood K. Szewczyk W. Nieuwenhuizen 1999 A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders Thromb Haemost 81 54 59
5. C. Caliezi N. Fünfsinn T. Mauron I. Baumgartner I. Sulzer M. Ulrich 1999 Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients Thromb Haemost 81 50 53
6. T. Kobayashi M. Nakamura M. Sakuma N. Yamada M. Sakon S. Fujita 2006 Incidence of pulmonary thromboembolism (PTE) and new guidelines for PTE prophylaxis in Japan Clin Hemorheol Microcirc 35 257 259
7. W.A. Wilson A.E. Gharavi T. Koike M.D. Lockshin D.W. Branch J.C. Piette 1999 International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 42 1309 1311
8. A. Hamano M. Umeda Y. Ueno S. Tanaka J. Mimuro Y. Sakata 2005 Latex immunoturbidimetric assay for soluble fibrin complex Clin Chem 51 183 188
9. G. Soe I. Kohno K. Inuzuka Y. Itoh M. Matsuda 1996 A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma Blood 88 2109 21017
10. T. Exner K.A. Rickard H. Kronenberg 1978 A sensitive test demonstrating lupus anticoagulant and its behavioural patterns Br J Haematol 40 143 151
11. H. Bounameaux P. de Moerloose A. Perrier M.-J. Miron 1997 D-dimer testing in suspected venous thromboembolism: an update QJM 90 437 442
12. L.A. Linkins S.M. Bates J.S. Ginsberg C. Kearon 2004 Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability J Thromb Haemost 2 1256 1260
13. T.E. Selim H.R. Ghoneim M.T. Khashaba S.A. Rakha 2005 Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis Haematologica 90 419 421
14. H. Wada T. Sase T. Matsumoto F. Kushiya M. Sakakura Y. Mori 2003 Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation Clin Appl Thromb Hemost 9 233 240
15. S. Ota H. Wada T. Nobori T. Kobayashi M. Nishio Y. Nishioka 2005 Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer Am J Hematol 79 274 280
16. G. Vogel C.E. Demplfle M. Spannagl W. Leskopf 1996 The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis Thromb Res 81 241 251
17. T. Kubo I. Kitajima A. Makinodan S. Niratsuka S. Inoue G. Otsuka 2001 Fibrin monomer could be a useful predictor of pulmonary embolism after total hip arthroplasty: preliminary report J Orthop Sci 6 119 122
18. G. Reber H. Bounameaux A. Perrier P. de Moerloose 1999 Performance of the fibrin monomer test for the exclusion of pulmonary embolism in symptomatic outpatients Thromb Haemost 81 221 223
19. I. Kitajima 2006 Soluble fibrin (SF) and fibrin monomer complex (FMC) J Jpn Soc Lab Hematol 7 470 477
20. J.S. Ginsberg P.S. Wells P. Brill-Edwards D. Donovan K. Moffatt M. Johnston 1995 Antiphospholipid antibodies and venous thromboembolism Blood 86 3685 36891
21. J.W. Ten Cate 1992 Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran Haemostasis 22 109 111
22. P.C. Comp T. Voegeli J.W. McCutchen V.A. Skoutakis A. Trowbridge W.L. Overdyke 1998 A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement Orthopedics 21 1123 1128
23. T. Ibbotson C.M. Perry 2002 Danaparoid: a review of its use in thromboembolic and coagulation disorders Drugs 62 2283 2314
24. D.G. Meuleman 1992 Orgaran (Org 10172): its pharmacological profile in experimental models Haemostasis 22 58 65
25. H. Wada H. Ikuma Y. Mori M. Shimura K. Hiyoyama T. Nakasaki 2000 Increased hemostatic molecular markers in patients undergoing anticoagulant therapy Semin Thromb Hemost 26 113 118